A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully ...

Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Rare tumors are defined as cancers with an incidence of less than 6 per 100,000 persons per year. Due to their low prevalence ...